# MIDAZOLAM IN 0.9% SODIUM CHLORIDE
> **ANDA218993** · Abbreviated New Drug Application (Generic) · Sponsor: GLAND · Approved 2024-08-12
## Drug
- **FDA Application Number:** ANDA218993
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** MIDAZOLAM IN 0.9% SODIUM CHLORIDE
- **Generic name:** MIDAZOLAM HYDROCHLORIDE
- **Active ingredients:** MIDAZOLAM
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** GLAND
- **Manufacturer:** Sagent Pharmaceuticals
- **First approval:** 2024-08-12
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218993)
---
*MORVS · CC0 1.0*